SLC30A8, CDKAL1, TCF7L2, KCNQ1 and IGF2BP2 are Associated with Type 2 Diabetes Mellitus in Iranian Patients.

Kazem Vatankhah YazdiSeyed Mehdi KalantarMassoud HoushmandMasoud RahmanianMasoud Reza ManaviatMohammad Reza JahaniBehnam KamalidehghanAmir Almasi-Hashiani

Published in: Diabetes, metabolic syndrome and obesity : targets and therapy (2020)

The prediction of refSNPs is remarkably needed for pharmacogenetics and pharmacogenomic approaches, in which the information would be useful for clinicians to optimize therapeutic strategies and adverse drug reactions in patients with T2DM.

Keyphrases

adverse drug
end stage renal disease
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
healthcare
metabolic syndrome
skeletal muscle
binding protein